期刊名称：MINI-REVIEWS IN MEDICINAL CHEMISTRY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The aim of Mini-Reviews in Medicinal Chemistry is to publish short reviews on the important recent developments in medicinal chemistry and allied disciplines.
The scope of Mini-Reviews in Medicinal Chemistry will cover all areas of medicinal chemistry including developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, drug targets, and natural product research and structure-activity relationship studies.
Mini-Reviews in Medicinal Chemistry is an essential journal for every medicinal and pharmaceutical chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
Instructions to Authors
Instructions for Authors
Manuscripts should be submitted openly to one of the following Editors without prior invitation at the following addresses:
Prof. A. Paul Krapcho
The University of Vermont
Department of Chemistry
Cook Physical Science Building
Burlington, Vermont
USA
Tel: (+1)-802 656-0271
Fax: (+1)-802 656-8705
E-mail: A.Paul.Krapcho@uvm.edu
Prof. Atta-ur-Rahman
H.E.J. Research Institute of Chemistry
University of Karachi
Karachi-75270
Pakistan
Tel: (+92)-21-482-4924 , (+92)-21-482-4925
Fax:(+92)-21-461-2073 , (+92)-21-497-7491, (+92)-21-497-5781, (+92)-21-481-9018, (+92)-21-481-9019
E-mail: mhej@cyber.net.pk
Dr. Patrice Talaga
Associate Director, Discovery Technologies
Global Chemistry, R&D
UCB
Chemin du Foriest
B-1420 Braine-l'Alleud
Belgium
Tel. (32.2) 386.27.27
Fax (32.2) 386.27.04
E-mail : patrice.talaga@ucb-group.com
Prof. M. Iqbal Choudhary
H.E.J. Research Institute of Chemistry
University of Karachi
Karachi-75270
Pakistan
Tel: (+92)-21-482-4924, (+92)-21-482-4925
Fax:(+92)-21-461-2073, (+92)-21-497-7491, (+92)-21-497-5781, (+92)-21-481-9018, (+92)-21-481-9019
E-mail: hej@cyber.net.pk
It is advisable that the authors submit an abstract to the Editor, prior to submitting the full manuscript. The submitted abstract should outline the intended contents and coverage of their article. The manuscript, written in English, should not exceed 25 pages in length and it should be typed in double spacing throughout on A-4 or US Letter (8.5x11 inches) paper. Dot matrix print or any print that is difficult to read is unacceptable. Two copies of the manuscript must accompany the original (along with a computer disk) and should be sent to the Editor at his given address. All pages should be numbered. Abbreviations should be defined the first time that they are used in the manuscript and a list of abbreviations used should also be provided.
Manuscript Organization: The manuscript should be divided as: Title page, abstract and the main text. The text may be subdivided further according to the areas to be discussed. This should be followed by the Acknowledgement (if any) and Reference sections. The first page should contain the title, the authors?names (initials and surname only), with an asterisk to mark the name of the principal author.
Conflict of Interest: Financial contributions to the work being reported should be clearly acknowledged, as should any potential conflict of interest.
Abstract: The abstract should not exceed 50 words and should condense the essential features of the review article, with the focus on the major advances in the field.
Key Words: Authors must supply up to eight key words along with their manuscript.
Text: The main text should begin on a separate page and it may be subdivided into separate sections. The review article should mention any previous important reviews in the field and contain a comprehensive discussion starting with the general background of the field. It should then go on to discuss the salient features of recent developments. The authors should avoid presenting material which has already been published in any previous review. The reference numbers should be given in square brackets in the text. Acknowledgements should be kept to a minimum.
Tables:
- Data Tables should be submitted in Microsoft Excel or in Microsoft Word table format.
- Each table should include a title/caption explaining what the table shows. Detailed legends may then follow.
- Tables should be given on separate pages with indications on the left hand margin to the text, as to the appropriate placement of the tables.
- Tables should not contain vertical rules.
- Columns and rows of data should be made visibly distinct by ensuring the borders of each cell display as black lines.
- Tables should be numbered consecutively in order of their citation in the body of the text, with Arabic numerals.
- If a reference is cited in both the table and text, insert a lettered footnote in the table to refer to the numbered reference in the text.
- Tabular data provided as additional files can be submitted as an Excel spreadsheet.
Figures / Illustrations:
All authors must strictly follow the guidelines below for preparing illustrations for publication in Mini-Reviews in Medicinal Chemistry.
Editorial Requirements:
The quality of the illustrations printed in the journal largely depends on the quality of the figures/illustration provided by the author. In preparing artwork or graphics for publication, keep in mind the following points.
- Submit the original artwork or a photographic print of the original for publication.
- Do not submit photocopies. (Hardcopy submission requirement).
- Illustrations should be provided as separate files, not embedded in the text. (Hardcopy submission requirement).
- Remove all color from graphics except for those illustrations (Greyscale), which are intended to be printed in color.
- Good quality of hardcopy originals are a requirement.
- Figures/illustrations cannot be modified or enhanced by the journal production staff.
- Figures should be referred to as “Fig. (1)? “Fig. (2)?etc. in the text with figure numbers in bold within round bracket.
- Revised manuscripts should contain a complete set of artwork and photographs.
Technical Details:
- Figures should be provided on high quality, white, smooth opaque paper. (Hardcopy requirement).
Format & Resolution:
- The following file formats can be accepted. (Preference in order of appearance): PDF, TIFF, JPEG, GIF.
- Illustrations must fit a single or double column format on the journal page, according to the following guideline below:
|
HEIGHT |
WIDTH |
|
SINGLE COLUMN |
24 cm (max) |
8.5 cm (max) |
|
DOUBLE COLUMN |
24 cm (max) |
18 cm (max) |
- Whenever possible, submit graphics that do not have to be reduced to fit the standard figure size.
- Use the best resolution available (hardcopy submission requirement). For online submission the maximum resolution is 300 dpi.
- Avoid textures and shadings giving a three-dimensional effect to the illustration.
- Symbols and lettering in the illustration should be of similar size.
- Smaller lettering is used.
- Font: Times New Roman or Helvetica is preferable. Font size: 10pt (maximum).
- Line drawings should have clear and sharp lines and should be of uniform density. Moreover, lines should be continuous without any breaks.
- Do not use lines thinner than 1 point.
Color Figures / Illustrations:
- One color plate will be published free of charge in each article. The cost for the first additional published page of color figures is US$ 635; the second additional page will be for US$ 465, and each subsequent page for US$ 315.
- Color figures should be supplied in CMYK not RGB colors.
- Required resolution for online submission is 300 dpi. In case of hardcopy submission, please use the maximum resolution available.
Photographs:
Submit high-contrast prints that are of single- or double-column width so that they will not have to be reduced when printed. Negatives are not acceptable. However, in case of hardcopy submission, color illustrations and plates can be published from 35 mm color slides.
Chemical Structures: Chemical structures must be prepared according to the guidelines below.
Structures should be prepared using a suitable drawing program e.g. ChemDraw and provided as separate file, submitted both on disk and in printed formats.
Numbers in bold should identify all chemical structure. If a name is also used to describe the compound, the associated number in bold should be in parenthesis, e.g. “compound (1)?
Structure Drawing Preferences:
[As according to the ACS style sheet]
Drawing Settings:
Chain angle 120?/P>
Bond spacing 18% of width
Fixed length 14.4 pt (0.500cm, 0.2in)
Bold width 2.0 pt (0.071cm, 0.0278in)
Line width 0.6 pt (0.021cm, 0.0084in)
Margin width 1.6 pt (0.096cm)
Harsh spacing 2.5 pt (0.088cm, 0.0347in)
Text settings:
Font Times New Roman / Helvetica
Size 10pt
Under the Preference Choose:
Units points
Tolerances 3 pixels
Under Page Setup Use:
Paper US letter
Scale 100%
References: For the format of references, see the ACS Style Guide, pp 106-114,
Examples:
Journal Reference:
Barton, D.H.R.; Brewster, A.G.; Ley, S.V.; Rosenfield, M.N. J. Chem. Soc. Chem. Commun., 1977, 147, 2356.
Book Reference:
Rahman, A.-U.; Shah, Z. Stereoselective Synthesis in Organic Chemistry, Springer-Verlag: New York, 1993.
Book Chapter Reference:
Wheeler, D.M.S.; Wheeler, M.M. In Studies in Natural Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier Science B. V: Amsterdam, 1994; Vol. 14, pp. 3-46.
Abstracts, unpublished data and personal communications (which can only be included if the permission has been obtained) should not be given in the reference section but they may be mentioned in the text with details provided as footnotes. All authors of referenced papers must be cited and there must be no use of the short hand version of et al. when citing the authors.
Manuscript Submission: Two copies of the manuscript must accompany the original along with the soft copy of the manuscript on a computer floppy disk(s) in MS Word file format (or created in any other well-known word processing software) should be submitted. To achieve rapid publication authors are encouraged to e-mail or fax their submission to the appropriate editorial office (see above) at the same time that they mail the manuscript. For even faster publication, authors are encouraged to submit their entire manuscript via Bentham’s online submission service (see below). Authors must provide their full address, telephone and fax numbers with e-Mail address with all submissions.
For expedient and speedy reviewing of author's manuscripts, authors are strongly advised to include the PDF file of their manuscript on a floppy or zip disk, into the mailing material. At the same time the package is mailed, please also send by e-mail a copy of the PDF file of the manuscript to the editorial office.
Online Manuscript Submission: (preferable)
To facilitate speedy and cost-effective submission of abstracts and manuscripts, an online submission and tracking service via Internet is being offered. Once the Editor-in-Chief of the journal has accepted your abstract, we would prefer that you submit your full manuscript online via our online submission service available at www.bentham-mps.org
For online submission, please provide your complete manuscript in the form of a single zipped folder containing all the material (main text, figures/ illustrations, scanned photographs, tables, chemical structures drawn in ChemDraw) as separate files and a PDF version of the entire manuscript with all the figures/ illustrations / tables / chemical structures etc., embedded in the text exactly in the manner as they should appear in printing.
Authors are required to proofread the PDF version of their manuscript before submission. The article will be published exactly as received and the Publishers will not be responsible for any error occurring in the manuscript in this regard.
For online submission of manuscripts, these should be submitted via our online manuscript submission service available at www.bentham-mps.org or by FTP submission at www.bentham-ftp.org
You may, however, still submit your abstracts and manuscripts through conventional surface mail.
Page Charges: No page charges will be levied to authors.
Proofs: Authors are sent page proofs. To avoid delays in publication, proofs should be checked immediately for typographical errors and returned within 48 hours. Major changes are not acceptable at the proof stage.
Copyright: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
Bentham Open Access: Accepted articles can be published online for an immediate free open access for all to view. Authors must pay for this service.
Reprints: Each first named author will receive a free copy of the journal issue in which their article is published. Reprints may be ordered from the Publisher. First named authors may also order a personal print and online subscription of the journal at 50% off the normal subscription rate by contacting the subscription department at e-mail: subscriptions@bentham.org
Reviewing and Promptness of Publication: All papers submitted for publication will be immediately subjected to editorial scrutiny, usually in consultation with members of the Editorial Advisory Board. Every effort will be made to assess the papers quickly and the decision conveyed to the authors normally within two weeks of the receipt of the paper. The papers will be typeset and the proofs dispatched to the authors normally within 4 weeks of their acceptance.
Please provide your telephone and fax numbers with your e-Mail address with all submissions.
Editorial Board
Co-Editors-In-Chief:
A. Paul Krapcho
The University of Vermont
Department of Chemistry
Cook Physical Science Building
Burlington,Vermont,USA
Tel: +1-802-656-0271
Fax: +1-802-656-8705
Email: A.Paul.Krapcho@uvm.edu
Patrice Talaga
Associate Director, Discovery Technologies
Global Chemistry, R&D
UCB S.A., Chemin du Foriest
B-1420 Braine-l'Alleud, Belgium
Tel: +32-23862727
Fax: +32-23862704
E-mail: Patrice.Talaga@UCB-Group.com
Atta-ur-Rahman
H.E.J. Research Institute of Chemistry
University of Karachi
Karachi-75270, Pakistan
Tel: +92-21-4824924
Fax:+92-21-4975781, 4977491, 4819018-19
E-mail: mhej@cyber.net.pk
M. Iqbal Choudhary
H.E.J. Research Institute of Chemistry
University of Karachi
Karachi-75270, Pakistan
Tel: +92-21-4824924
Fax:+92-21-4819018-19
E-mail: hej@cyber.net.pk
Regional Editors:
Daniela Barlocco (Ist. Chim. Farm. Toss., Milano, Italy)
Masereel Bernard (University of Namur, Namur, Belgium)
Gildas Bertho (Universit?Ren?Descartes Paris, Paris, France)
Peter Chiba (Universität Wien, Vienna, Austria)
Paola Conti (Istituto di Chimica Farmaceutica Milano, Italy)
Maria Paola Costi (Universit?degli Studi di Modena, Modena, Italy)
Alain Gueiffier (Universite Tours, Tours, France)
S.M. Husbands (University of Bath, Bath, UK)
Reuben Jih-Ru Hwu (Tsing Hua University, Hsinchu, Taiwan)
Huba Kalasz (Semmelweis University, Budapest, Hungary)
Yoshiyuki Kawakami (Eisai Co., Ltd., Ibaraki, Japan)
Maria Luz Lopez-Rodriguez (University of Madrid, Madrid, Spain)
Antonello Mai (Universita degli Studi di Roma, "La Sapienza", Roma, Italy)
Ana Martinez (Neuropharma, Madrid, Spain)
Raimund Mannhold (Heinrich-Heine-Universitat, Dusseldorf, Germany)
Chris Meier (Universitaet Hamburg, Hamburg, Germany)
Frederic Ooms (Euroscreen S.A., Gosselies, Belgium)
Teruyuki Sakai (Kirin Brewery Co., Ltd., Gunma, Japan)
Shalom Sarel (The Hebrew University of Jerusalem, Jerusalem, Israel)
K.R. Scott (Howard University, Washington, DC, USA)
Graeme Semple (Arena Pharmaceuticals, San Diego, CA, USA)
Hisashi Shinkai (JT Inc., Osaka, Japan)
Masaaki Suzuki (Gifu University, Gifu, Japan)
Nikos Tagmatarchis (Theoretical and Physical Chemistry Institute, Athens, Greece)
B.K. Trivedi (Pfizer Global Research & Development, MI, USA)
Sonja Visentin (Universit?di Torino, Turin, Italy)
Karl Werbovetz (The Ohio State University, Columbus, OH, USA)
Ross Mcgeary (The University of Queensland, Brisbane, Australia)
Boulos Zacharie (Prometic Biosciences Inc, Laval QC H7V 5B7, Canada)
Editorial Advisory Board:
Andrew Abell (University of Canterbury, Christchurch, New Zealand)
Syed M. Ali (ArQule Inc., Woburn, MA, USA)
K.H. Altmann (Novartis Pharma AG, Basel, Switzerland)
Rathindra Bose (Northern Illinois University, DeKalb, IL, USA)
Hugo Cerecetto (Dep. Quimica Organica, Montevideo, Uruguay)
Ji-wang Chern (National Taiwan University, Taipei, Taiwan)
Erik de Clerq (Katholieke Universiteit Leuven, Leuven, Belgium)
Asim K. Debnath (Lindsley F. Kimball Research Institute, NY, USA)
Albena Todorova Dinkova-Kostova (Johns Hopkins University, MD, USA)
Jean-Michel Dogn?/B> (University of Liége, Liége, Belgium)
Yuxiang Dong (University of Nebraska Medical Center, Omaha, NE, USA)
Solo Goldstein (Institut de Recherches Servier, Suresnes, France)
Margaret M. Harding (University of Sydney, Sydney, Australia)
Andreas Hilgeroth (Martin-Luther-University, Halle, Germany)
Terry C. Jenkins (University of Bradford, Bradford, UK)
Tomas Girbes (Universidad de Valladolid, Vallodolid, Spain)
Mankil Jung (Yonsei University, Seoul, Korea)
Dirk C.M. Leysen (Organon, Oss. The Netherlands)
Jean-Françios Liegeois (University of Liege, Liege, Belgium)
Ian A. McDonald (Pharmaxis Ltd., Frenchs Forest, Australia)
S. Mehta (Ambit Biosciences, San Diego CA, USA)
Martin Missbach (Novartis Pharma AG, Basel, Switzerland)
Guillermo A. Morales ( Telik, Inc, Palo Alto, CA, USA)
Christa E. Mueller (Universitaet Bonn, Bonn, Germany)
Sunil Nagpal (Eli Lilly and Company, Indianapolis, IN, USA)
Ion Niculescu-Duvaz (Centre for Cancer Therapeutics, Surrey, UK)
George Perry (Case Western Reserve University, Cleveland, Ohio, USA)
Georg Petroianu (der Universitaet Heidelberg, Mannheim, Germany)
Krzysztof W. Pankiewicz (Pharmasset, Inc., Tucker, GA, USA)
Patrick Perlmutter (Monash Univ., PO Box 23, Victoria, 3800, Australia)
Ronald James Quinn (AstraZeneca Nathan, Australia)
Patricia H. Reggio (Kennesaw State University, Kennesaw, GA, USA)
Juan B. Rodriguez (Universidad de Buenos Aires, Buenos Aires, Argentina)
David P. Rotella (Lexicon Pharmaceuticals, Princeton, NJ, USA)
Basil Roufogalis (University of Sydney, Sydney, Australia)
Wendy Sanderson (Johnson & Johnson Pharmaceutical R& D, Beerse, Belgium)
Patrick M. Sexton (The University of Melbourne, Melbourne, Australia)
Yuntao Song (Pfizer Global Research & Development, MI, USA)
Kumiko Takeuchi (Eli Lilly and Company, Indianapolis, IN, USA)
Shinji Terao (Shinsenri Minamimachi, Osaka, Japan)
Samuel Toba (Signature Bioscience, San Francisco, CA, USA)
Istvan Toth (The University of Queensland, Queensland, Australia)
David J. Triggle (University at Buffalo, Buffalo, NY, USA )
Paolo Truffa-Bachi (Institut Pasteur, Paris Cedex, France)
Susan Shwu-Chen Tsay (Well-being Biochemical Corp., Taiwan)
|
